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A simple and fast alternative methodology using capillary zone electrophoresis (CZE) to analyze linezolid 
and its cationic photodegradation products in tablets has been developed. The separation was carried 
out on fused silica capillary and conducted using 100 mM formic acid (pH 3.0) and by applying 30 
KV voltage. Detection was performed at UV 254 nm. The optimized method was validated in terms of 
linearity, limits of detection and quantification, precision (repeatability), stability studies (selectivity) and 
accuracy. Good linearity (8-20 mg L-1) was obtained and the limit of detection was 0.95 mg L-1. The greatest 
advantages of the CZE method were the rapid set-up of instrumentation and capillary equilibration, short 
analysis time (12 min), low running cost and low waste generation. The method showed good stability 
in determining linezolid submitted to degradation by light and to a climatic chamber and can be used as 
an alternative for evaluation in stability studies of linezolid in tablets, as well as for the analysis of the 
drug in raw materials and finished products.
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INTRODUCTION
Linezolid, N-(((S)-3-(3-Fluoro-4-morpholino-
phenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide 
(Figure 1), is a member of a new class of antibiotics, the 
oxazolidinones (Marchese,  Schito, 2001), and it was 
the first oxazolidinone to be developed and approved 
for clinical use (Di Paolo et al., 2010). Linezolid (LNZ) 
is currently the only antimicrobial agent which can be 
administered orally, being rapidly absorbed following 
oral administration and eliminated via renal and non-renal 
routes (Boak et al., 2014). It is particularly important 
in cases where intravenous access is difficult and the 
patients require outpatient therapy (Itani et al., 2005; 
Kalil, Puumala, Stoner, 2006). LNZ has a wide spectrum 
of activity against gram-positive organisms and appears 
to be an effective option of treatment when compared to 
vancomycin (Patel, Gallagher, 2015; Silva, Monteiro Neto, 
Sejas, 2007).
Analysis of LNZ and its degradation products 
are usually assayed by high-performance liquid 
chromatography (HPLC) and spectrometry (Erlich 
et al., 2001; Krishna-Reddy et al., 2002; Patel et al., 
FIGURE 1 - Chemical structure of Linezolid (LNZ) and 
Imidazole (IS) used in the study.
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2007; Merli et al., 2011; La Marca et al., 2012; Cios, 
Kus, Szymura-Oleksiak, 2013; Chavda et al., 2016); 
however, this technique has important limitations 
such as the high cost of the analysis and the excessive 
generation of residues due to the use of organic solvents. 
Capillary electrophoresis (CE) has also been described 
as an alternative to HPLC for LNZ assays. The range of 
pharmaceutical applications of CE is similar to HPLC 
and its advantages include appreciably short analysis 
times, low residue generation, use of aqueous solvents, 
high resolution and specificity (Landers, 1997). CE 
presents several modes of operation, with zone capillary 
electrophoresis (CZE) and micellar electrokinetic 
capillary chromatography (MEKC) being the most 
commonly used. 
MEKC has been used to determine LNZ in human 
serum samples (Kitahashi, Furuta, 2002). The authors 
used 25 mM borate buffer (pH 10.0) containing 80 mM 
sodium dodecyl sulphate (SDS) as running buffer. They 
compared CZE and MEKC and concluded that MEKC 
enabled a separation (with a migration time of 14 min) 
without overlapping with the peaks of impurities in 
serum and improvement in the theoretical plate number. 
An improvement of the method was published by the 
same authors in 2004 (Kitahashi, Furuta, 2004) lowering 
the pH of borate buffer (pH 8.0) and the concentration of 
SDS (50 mM). There was the addition of 7 M urea as an 
additive to increase the LNZ dissolution into the running 
buffer. The advantages included direct serum injection 
without pretreatment and lower migration time (5.5 
min). CE was also used for the separation of enantiomers 
from LNZ (Michalska, Pajchel, Tyski, 2008a; Bednarek, 
Bocian, Michalska, 2008). Michaska, Pajchel, and Tyski 
(2008a) used MEKC to performed the LNZ enantiomeric 
separation. Charged β-cyclodextrins (β-CD) was added 
to the running buffer to carry out the separation with a 
migration time of 15 min.
Due to its chemical structure, LNZ is highly unstable 
under alkaline conditions and several degradation studies 
have been done to evaluate the compounds obtained 
under conditions of alkaline stress. Alkaline degradation 
and photodegradation products have been investigated 
by chromatography and spectrophotometry in LNZ 
commercial (tablets) and injectable samples (Bebawy, 
2003; Lopes, Salgado, 2009; Lopes, Salgado, 2010; Kawy, 
Weshahy, Shokry, 2012; Hegazy et al., 2014). Chiral 
impurities from LNZ have been analyzed by MEKC in 
linezolid solution for infusion (Michalska, Pajchel, Tyski, 
2008b).
CZE has never been used in LNZ tablet assay 
until now. The few scientific papers addressing CE for 
linezolid applied MEKC to LNZ samples in the injectable 
form. The aim of this work was to develop a stability-
indicating CZE/UV assay method to analyze linezolid in 
the cationic form (under pH 4.0), which can be applied 
to studies of stability and determination of content of 
linezolid in the presence of degradation products. This 
is the first paper that uses CZE to analyze linezolid in its 
pharmaceutical form of tablets.
MATERIAL AND METHOD
Chemicals
All chemicals were of analytical grade and used as 
received. LNZ reference substance was obtained from 
“Synfine research” Chemical Company (Canada) and 
HPLC analysis showed that it contained 99.3 % of LNZ. 
Linezolid tablets (Zyvox®) were commercially obtained 
and were claimed to contain 600 mg of active drug (Pfizer, 
Brazil). Imidazole (purity 99.0%) from Merck was used as 
internal standard. Formic acid 85% was purchased from 
Synth. Ultrapure water was deionized by using a Milli-Q 
gradient system A10 (Millipore, Bedford, MA, USA) and 
was used to prepare all buffers.
Equipment
CE analyses were performed on a model PA800 Plus, 
Beckman Coulter, equipped with a UV/Vis detector. Bare 
fused silica capillaries with 75 µm i.d. were purchased 
from Polymicro Technologies, Phoenix, AZ, U.S.A. The 
capillary detection length was 50 cm and the total length 
60 cm. The samples were injected by pressure (10s at 0.5 
psi) and the detection was performed at 256 nm. Stock 
solutions of formic acid (1 M) were prepared in water 
and stored under refrigeration. Working background 
electrolyte consisted of 100 mM formic acid (pH 3.0) and 
the applied voltage was 30 kV.
Pre-treatment of capillary
The capillary was conditioned with 1 M NaOH 
for 30 min, followed by the passage of ultra pure water 
(Milli-Q) for 10 min and a running buffer for 20 min. 
At the beginning of each working day, the capillary was 
conditioned with a flush of NaOH (5 min), ultrapure water 
(5 min) and electrolyte (10 min). Between each running, 
the capillary was washed with 1 M NaOH followed by 
ultrapure water for 2 min and with background electrolyte 
for 5 min.
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Preparation of the solutions 
Preparation of standard solution and internal standard
Stock solutions of LNZ (reference substance) and 
imidazole (internal standard) were prepared in deionized 
water. Linezolid stock solution was prepared by accurately 
weighing 10 mg of linezolid in a 100 mL volumetric flask, 
and then dissolving this quantity in deionized water. The 
solution was sonicated for 10 min and brought to volume 
with water. For the calibration curve, working standard 
solutions were prepared by dilution of the linezolid stock 
solution to obtain six different concentrations within 
the range of interest, in this case, 8–20 mg mL-1. All the 
solutions were prepared in triplicate.
Preparation of sample solution
An amount of powder equivalent to 500 mg LNZ 
was transferred to a 1000 mL volumetric flask with 
deionized water and shaken for 20 min, followed by the 
dilution to volume with deionized water (500 mg L-1). A 
10 mL aliquot of this solution was transferred to a 100 
mL volumetric flask (50 mg L-1). Lastly, an aliquot of this 
solution was dissolved in the deionized water to obtain 
a solution with a final concentration of 12 mg L-1. This 
solution was used in the stability studies and in the assay 
of commercial tablets of linezolid.
Method validation
The method validation assays were carried 
out according to the International Conference on 
Harmonization Guidelines (ICH, 2005). The analyzed 
parameters were: linearity, limits of detection and 
quantification, precision (repeatability), selectivity, 
accuracy.
Linearity
For the assay of linearity stock solutions of LNZ 
reference substance were prepared at six concentration 
levels from 8.0-20 mg L-1 and injected in triplicate. The 
linearity was evaluated by the least square regression 
method. 
Limits of detection and quantification
The limits of detection (LOD) and quantification 
(LOQ) were calculated according to the equations: 
LOD = 3 Sy/x /b and LOQ = 10 Sy/x /b
Precision
The precision of the method was evaluated by the 
repeatability (intra-assay). Repeatability of the method 
was studied by analyzing samples of tablets, at the 
same concentration, within 1 day and under the same 
experimental conditions.
Stability studies (Selectivity)
Selectivity and forced degradation studies were 
conducted according to the ICH Guidelines by introducing 
a sample of linezolid sample solution to different forced 
degradation conditions using thermal and photolytic 
analysis. For the selectivity test of the proposed method, 
tablet powder of LNZ was prepared and exposed to light 
(254 nm) and climate chamber (40 oC/75% for 90 days) 
to determine the effects of irradiation and humidity/
temperature on the stability of LNZ in its solid state and 
was subsequently analyzed.
Accuracy
The accuracy of the method was evaluated by 
comparing the results obtained in the simultaneous 
determination of linezolid tablets by HPLC and capillary 
electrophoresis. Upon test “t-paired” it was found that the 
average values obtained by the two techniques did not 
differ significantly at a confidence level of 95%.
RESULTS AND DISCUSSION
Optimization CE/UV separation 
In capillary electrophoresis, the choice of buffer 
or background electrolyte has direct implications for the 
optimization of separation since the pH of the electrolyte 
determines the effective mobility by decisively affecting 
the degree of dissociation (Landers, 1997). For basic 
compounds, it is recommended that the pH of the 
background electrolyte is around 2.5. This would provide 
better selectivity since acidic or neutral interferents 
exhibit negative mobility or simply do not have mobility, 
respectively, thus not being detected. Although LNZ does 
not have basic character, it has a nitrogen atom, which 
can be ionized and migrated as cation in CZE. Michalska, 
Pajchel and Tyski (2008a) studied the influence of pH on 
the behavior of LNZ in CE and found that it is protonated 
under pH 4.0 (LNZ has pKa around 1.8).
In this study formic acid under pH 3.0 was used 
as background electrolyte. Formic acid showed a good 
baseline at the work concentration (100 mM). Figure 2 
shows the electropherogram of LNZ standard and the 
blank sample. Imidazole was used as internal standard and 
methanol as a marker of electroosmotic flow (EOF). It can 
be observed that the LNZ peak migrates before the EOF, 
which ensures that it is still protonated at this pH; however, 
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as the EOF is smaller and the electrophoretic mobility is 
also low, it takes 12 minutes to migrate.
Method validation
The method was validated in respect to parameters 
including linearity, limits of detection (LOD) and 
quantitation (LOQ), precision, stability studies (selectivity) 
and accuracy. 
Linearity, limits of detection and quantitation
Linearity studies were performed by linear 
regression standard curve. Lower values of parameters 
like standard error (S.E.) of slope and intercept (Table I) 
indicated high precision of the proposed methods. Also, 
the mean slope and intercept values are within the 95% 
confidence interval. Goodness of fit of the regression 
equations was supported by high regression coefficient 
values and lower calculated F-values (Table I). With 
data from the evaluation of linearity, we calculated the 
limits of detection (LOD), quantification (LOQ) and the 
determination coefficient (r2), which are presented in 
Table I. This analysis was done at 95 % confidence and 5 
% significance level.
Precision
The data obtained from precision experiments are 
given in Table II for intra-day precision studies. Each 
concentration was injected six times (n = 6). The % 
RSD values for intra-day precision study was < 4.0% 
confirming that the method was sufficiently precise 
(Table II).
Stability studies (Selectivity)
Figure 3 presents the electropherograms of LNZ 
tablet submitted to degradation by light. The sample 
of LNZ was injected in high concentration to visualize 
the degradation products. The appearance of two major 
peaks (1 and 2) can be observed, corresponding to 
cationic degradation products in just 10 days of exposure 
to light (LNZ solid state). These degradation products 
probably contain nitrogen in their structure, which 
is protonated at this pH and migrate as cationic form 
during electrophoresis. It is noted that the elution of 
FIGURE 2 - CZE of (A) – Blank sample, (B) - linezolid 
(chemical reference). CE/UV conditions: 100 mM formic acid, 
pH 3.0, applied voltage +30 kV, injection by pressure (0.5 psi for 
10s) and detection at 254 nm. Caption: methanol as eof marker 
and imidazole as IS (internal standard).
TABLE I - Statistical analysis of calibration graphs and analytical 
data in the determination of linezolid by electrophoresis method 
(n=6)
Parameters Proposed electrophoresis method
Regression analysis
Slope (S.E.a) 275.30 (6.27)
Intercept (S.E.a) -226.46 (87.22)
Correlation coefficient (r2) 0.9943
Equation y = 275.30x – 226.46
Analysis of variance
Linear regressionb 1926.1430
Validation parameters
Linearity (mg L-1) 8-20
 LOD (mg L-1) 0.95
LOQ (mg L-1) 3.16
a Standard error of mean. b Corresponding critical values for F 
at p < 0.05
TABLE II - Comparison of CE and HPLC methods for 
determination of linezolid in Tablets (600 mg)
CE assay 
(content,%)
HPLC method 
(content, %)
Results 100.91 
98.64 
99.14 
106.84 
105.71 
107.56
103.5 
100.32 
100.81 
105.00 
101.31 
101.31
Mean 103.13 102.04
Number of samples 6 6
R.S.D. (%) 3.90 1.77
tcalculated* 0.73
*Student’s t-value for p = 0.05, n = 6, t tabulated = 2.447
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these degradation products are very close, assuming that 
the chemical structures are very similar. During 90 days 
of exposure in the UVC light the degradation products 
primarily formed, increasing over the course of time, 
indicating that these products can be characterized as 
primary products of degradation of linezolid submitted 
to light exposure. Figure 4 shows the electropherogram 
of linezolid tablet subjected to degradation in a climatic 
FIGURE 3 - Electropherogram of photodegradation products of LNZ tablet submitted to light UVC (254 nm). 
FIGURE 4 - Electropherogram of degradation products of LNZ tablet submitted to climate chamber (40 oC/75 %). 
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chamber (40oC/75%). The degradation in the solid state 
is slow and time consuming, but it is consistent with 
the adverse conditions of temperature and humidity in 
different countries during transport and distribution of 
this drug. In this analysis, we can watch the beginning of 
the formation of degradation products after 30 days. This 
electropherogram is consistent with the data obtained 
earlier by HPLC (Lopes, Salgado, 2009). 
Accuracy
With the statistics of the two methods analyzed, it 
was found that there is no statistical difference between 
the methods, confirming the accuracy of the method by 
capillary electrophoresis (Table II).
Analysis of pharmaceutical tablets
The validated method was applied for the assay of 
commercial tablets containing 600 mg of linezolid. Results 
of the determination were found to be 103.13 ± 3.90% 
(RSD). The method was statistically compared with the 
HPLC method (Table II). The averages of the validated 
methods were compared by t-test and statistical differences 
were not observed between them.
CONCLUSION
In this work the linezolid tablets and its cationic 
degradation products were determined by CZE in low pH. 
This simple and validated methodology provided good 
linearity, precision and detection limits. CZE method was 
shown to be specific because there was no interference of 
the excipients present in the formulation of the linezolid 
tablets, as well as showing the ability to distinctly 
determine the LNZ from its degradation products. It could 
be used as an alternative to HPLC in the determination 
of the content and stability in studies of the LNZ tablets.
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